le mercredi 17 octobre 2018, à 04:33. Posté
par Marion
Insufficient funds http://www.caughtinthecrossfire.com/1-800-pharmrxcom-d654.pdf#owen naturalhealthconsultancy.com Alexion specializes in treatments for very rare diseases - amarket niche that has become popular with pharmaceuticalcompanies seeking products for which they can charge very highprices. Drugs for rare diseases can command prices of more than$500,000 a year, and have been highly profitable for otherbiotech companies.